Project Oncology®

195 Folgen

1. Redefining Cancer Care with Functional Precision Medicine

   Vom: 14.8.2025
2. Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma

   Vom: 7.8.2025
3. Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies

   Vom: 6.8.2025
4. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Vom: 4.8.2025
5. Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization

   Vom: 29.7.2025
6. Analyzing Toxicity Trends Post-CAR T-Cell Therapy: Implications for Patient Monitoring

   Vom: 23.7.2025
7. Sickle Cell Disease Care: Balancing Disease-Modifying and Curative Therapies

   Vom: 22.7.2025
8. Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks

   Vom: 21.7.2025
9. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Vom: 23.6.2025
10. Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care

    Vom: 10.6.2025
11. Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden

    Vom: 5.6.2025
12. Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery

    Vom: 5.6.2025
13. Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study

    Vom: 3.6.2025
14. Trial in Progress: Phase 3 MoonRISe-3 Study

    Vom: 1.5.2025
15. First Results From Cohort 4 of the SunRISe-1 Trial

    Vom: 1.5.2025
16. HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

    Vom: 15.4.2025
17. Targeting CD123 in AML: The Latest Therapeutic Advancements

    Vom: 11.4.2025
18. Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

    Vom: 7.4.2025
19. Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

    Vom: 28.3.2025
20. AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy

    Vom: 14.3.2025